부산대학교 도서관

Volk JE; Hessol NA; Gray GE; Kublin JG; Churchyard G; Mlisana K; Nchabeleng M; Buchbinder SP; Bekker L

Retrovirology, Vol 9, Iss Suppl 2, p P131 (2012)

Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Williams LD; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Chen S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Seaton KE; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Sawant SS; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Zhang L; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Heptinstall J; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.; Liu S; Worcester HIV Vaccine, Worcester, MA, USA.; Grunenberg N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Tomaka F; Department of Research & Development, Janssen Vaccines and Prevention/Johnson & Johnson, Titusville, NJ, USA.; Rerks-Ngarm S; Thai Ministry of Public Health, Nonthaburi, Thailand.; Pitisuttithum P; Vaccine Trials Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Nitayaphan S; Royal Thai Army, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.; Ake JA; U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Vasan S; U.S. Military HIV Research Program, CIDR, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.; Pantaleo G; Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Frank I; Infectious Diseases Division, Perelman School of Medicine, University of Pennsylvania, PA, USA.; Baden LR; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Keefer M; Department of Medicine, University of Rochester, Rochester, NY, USA.; Chirenje M; College of Health Sciences Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.; Hosseinipour MC; UNC-Project Malawi, Lilongwe, Malawi.; Department of Medicine, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Mngadi K; Clinical Research Division, Aurum Institute, Johannesburg, South Africa.; Laher F; Perinatal HIV Research Unit (PHRU), Wits Health Consortium, Faculty of Health Sciences, University of the Witwatersrand, Soweto, Johannesburg, South Africa.; Garrett N; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; De Rosa S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Lu S; Worcester HIV Vaccine, Worcester, MA, USA.; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Gray GE; Perinatal HIV Research Unit (PHRU), Wits Health Consortium, Faculty of Health Sciences, University of the Witwatersrand, Soweto, Johannesburg, South Africa.; South African Medical Research Council, Cape Town, South Africa.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Tomaras GD; Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

Mkhize NN; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Brackett C; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Elyanu PJ; Baylor College of Medicine Children's Foundation-Uganda, Kampala, Uganda.; Tapley A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Cape Town, Cape Town, South Africa.; Dadabhai S; Johns Hopkins Research Project, Blantyre, Malawi.; Hu J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Do BTN; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Schuster DJ; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Heptinstall J; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Sawant S; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Seaton K; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Sarzotti-Kelsoe M; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Hudson A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Jin Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Bhebhe S; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Kaldine H; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Kgagudi P; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Modise T; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Mgodi NM; Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.; Andriesen J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Randhawa AK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Peng J; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Kenny A; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Duke Global Health Institute, Duke University, Durham, NC, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Chen Z; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Pennsylvania, PA, USA.; Heng S; Department of Biostatistics, School of Global Public Health, New York University, New York, NY, USA.; Villaran M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Takalani A; Hutchinson Center Research Institute of South Africa, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa.; Le Roux B; Hutchinson Center Research Institute of South Africa, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa.; Wilkinson E; KwaZulu-Natal Research Innovation & Sequencing Platform, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response & Innovation, Stellenbosch, South Africa.; Odhiambo J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hutchinson Center Research Institute of South Africa, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa.; Shah P; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Polakowski L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Yacovone M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Samandari T; COVID-19 Prevention Network, Seattle, WA, USA.; Chirenje Z; Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.; Makhema J; Botswana Harvard AIDS Institute, Gaborone, Botswana.; Kamuti E; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.; Njekwa K; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.; Nuwagaba-Biribonwoha H; ICAP at Columbia University, Eswatini Prevention Center, Mbabane, Eswatini.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.; Baguma A; Baylor College of Medicine Children's Foundation-Uganda, Kampala, Uganda.; Badal-Faesen S; Clinical HIV Research Unit / Helen Joseph Clinical Research Site, Johannesburg, South Africa.; Brumskine W; The Aurum Institute, Rustenburg Clinical Research Site, Rustenburg, South Africa.; Coetzer S; Synexus Helderberg, Cape Town, South Africa.; Dawson R; University of Cape Town Lung Institute Clinical Research Site, Cape Town, South Africa.; Delany-Moretlwe S; Wits RHI University of the Witwatersrand, Johannesburg, South Africa.; Diacon AH; TASK, Cape Town, South Africa.; Fry S; FAMCRU Family Clinical Research Unit, Cape Town, South Africa.; Gill K; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Madikida A; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Hoosain ZAE; Josha Research Clinical Research Site, Bloemfontein, South Africa.; Hosseinipour MC; Malawi Clinical Research Site, Lilongwe, Malawi.; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, CA, USA.; Inambao M; CFHRZ - Ndola Clinical Research Site, Ndola, Zambia.; Innes C; The Aurum Institute, Klerksdorp Clinical Research Site, Klerksdorp, South Africa.; Innes S; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Kalonji D; South African Medical Research Council, Isipingo Clinical Research Site, KwaZulu-Natal, South Africa.; Mwape H; UNC Global Projects / Kamwala District Health Centre, Lusaka, Zambia.; Kassim P; Soweto - Kliptown Clinical Research Site, Soweto, South Africa.; Kamanga MC; Johns Hopkins Research Project-Kamuzu University of Health Sciences, Blantyre, Malawi.; Kilembe W; CFHRZ Clinical Research Site, Lusaka, Zambia.; Laher F; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa.; Malahleha M; Synergy Biomed Research Institute, East London, South Africa.; Maluleke VL; MERC Middelburg, Middelburg, South Africa.; Mboya G; Kisumu Clinical Research Site, Kisumu, Kenya.; Madiega PA; Kenya Medical Research Institute, Nairobi, Kenya.; McHarry K; TASK Eden, Western Cape, South Africa.; Mitha E; Newtown Clinical Research, Johannesburg, South Africa.; Duki Y; Aurum Tembisa Clinic 4, Gauteng, South Africa.; Mda P; Nelson Mandela Academic Clinical Research Unit, Walter Sisulu University, Mthatha, South Africa.; Moerane M; Nelson Mandela Academic Clinical Research Unit, Walter Sisulu University, Mthatha, South Africa.; Moloantoa T; PHRU Matlosana Clinical Research Site, Klerksdorp, South Africa.; Nuwamanya S; Joint Clinical Research Centre, Lubowa, Uganda.; Mahomed S; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Naicker V; South African Medical Research Council, Tongaat Clinical Research Site, KwaZulu-Natal, South Africa.; Nana A; Soweto - Kliptown Clinical Research Site, Soweto, South Africa.; Nanvubya A; UVRI-IAVI HIV Vaccine Program Ltd. Clinical Research Site, Entebbe, Uganda.; Kawoozo B; UVRI-IAVI HIV Vaccine Program Ltd. Clinical Research Site, Entebbe, Uganda.; Nchabeleng M; MeCRU Clinical Research Site, Pretoria, South Africa.; Otieno W; Kombewa Clinical Research Site, Kisumu, Kenya.; Maseno University School of Medicine, Kisumu, Kenya.; Potgieter EL; Synexus Stanza Clinical Research Centre Clinical Research Site, Pretoria, South Africa.; Potloane D; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Punt Z; PHOENIX Pharma (Pty) Ltd, Port Elizabeth, South Africa.; Said J; Moi University Clinical Research Centre, Eldoret, Kenya.; Singh Y; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Kassim S; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; van der Vendt D; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Tayob MS; MERC Kempton, Kempton, South Africa.; Vahed Y; MERC Welkom, Welkom, South Africa.; Wabwire DO; MU-JHU Research Collaboration Clinical Research Site, Kampala, Uganda.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Gray GE; South African Medical Research Council, Pretoria, South Africa.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Global Health, University of Washington, Seattle, WA, USA.; Kotze P; Qhakaza Mbokodo Research Clinic, Ladysmith, South Africa.; Garrett N; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Ferrari G; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Montefiori D; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA.; Moore PL; National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, SAMRC Antibody Immunity Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Tomaras GD; Departments of Surgery and Integrative Immunobiology, Center for Human Systems Immunology, Duke University, Durham, NC, USA. gdt@duke.edu.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. pgilbert@fredhutch.org.; Department of Biostatistics, University of Washington, Seattle, WA, USA. pgilbert@fredhutch.org.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. pgilbert@fredhutch.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Parks KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Allen MA; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.; Yen C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.; Furch BD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; MacPhee KJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ozorowski G; Department of Integrative, Structural, and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Heptinstall J; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics, and Microbiology, Duke University, Durham, NC 27701, USA.; Hahn WO; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Zheng Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Lu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Grant S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Domin E; Duke University Medical Center, Durham, NC 27701, USA.; Duff MO; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Seese A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Marini-Macouzet C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ballweber-Fleming L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Lee WH; Department of Integrative, Structural, and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Cottrell CA; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Liguori A; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Georgeson E; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Alavi N; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Kubitz M; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Phelps N; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Seaton KE; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics, and Microbiology, Duke University, Durham, NC 27701, USA.; Cohen KW; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Anderson MA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Mondal K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Laufer DS; IAVI, New York, NY 10004, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ward AB; Department of Integrative, Structural, and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.; Himansu S; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Leav B; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Reuter C; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Tomaras GD; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics, and Microbiology, Duke University, Durham, NC 27701, USA.; Montefiori D; Duke University Medical Center, Durham, NC 27701, USA.; Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Frank I; Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.; Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35205, USA.; Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Van Tieu H; New York Blood Center, New York, NY 10017, USA.; Keefer MC; Infectious Diseases Division, Department of Medicine, University of Rochester, Rochester, NY 14627, USA.; Clark J; Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA.; Riddler SA; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Schief WR; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Riddler SA; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania (S.A.R.).; Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Clark J; Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California (J.C.).; Yen C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland (C.Y., M.Allen).; Allen M; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland (C.Y., M.Allen).; Furch BD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Lu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Grant S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Mondal K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Anderson M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Lemos MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (S.R.W., L.R.B.).; Sobieszczyk ME; Division of Infectious Diseases, Aaron Diamond AIDS Research Center, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, New York (M.E.S.).; Frank I; School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (I.F.).; Goepfert P; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama (P.G.).; Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts (K.E.S.).; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (S.R.W., L.R.B.).; Tieu HV; Division of Infectious Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian Columbia University Irving Medical Center, and Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York (H.-V.T.).; Keefer MC; Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York (M.C.K.).; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington (Z.M., B.D.F., H.L., S.G., K.M., M.Anderson, J.M., M.P.L., A.S.W.D., M.J.M., J.G.K., L.C.).

Publisher: American College of Physicians--American Society of Internal Medicine Country of Publication: United States NLM ID: 0372351 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1539-3704 (Electronic) Linking ISSN: 00034819 NLM ISO Abbreviation: Ann Intern Med Subsets: MEDLINE

Duncombe CJ; Graduate Program in Pathobiology, Department of Global Health, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA.; Hergott DEB; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA; Institute of Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.; Staubus W; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA.; Balke-Buijs M; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.; Kublin JG; Seattle Malaria Clinical Trials Center, Fred Hutch Cancer Research Center, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Healy SA; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Talley A; Spero Therapeutics, Cambridge, MA, USA.; Jackson L; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.; Sim BKL; Sanaria, Rockville, MD, USA.; Hoffman SL; Sanaria, Rockville, MD, USA.; Sauerwein RW; Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, Netherlands.; Roestenberg M; Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.; Murphy SC; Graduate Program in Pathobiology, Department of Global Health, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA; Seattle Malaria Clinical Trials Center, Fred Hutch Cancer Research Center, Seattle, WA, USA; Department of Microbiology, University of Washington, Seattle, WA, USA; Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA. Electronic address: murphysc@uw.edu.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

Seshadri C; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA; Seattle Tuberculosis Research Advancement Center, Seattle, WA, USA. Electronic address: seshadri@uw.edu.; Flynn JL; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.; Maiello P; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.; Schnappinger D; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY, USA.; Wilkinson RJ; Wellcome Discovery Research Platform in Infection, Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, South Africa; Department of Infectious Diseases, Imperial College London, London, UK; Francis Crick Institute, London, UK.; Gordon SB; Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK; Malawi-Liverpool-Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.; Mwandumba HC; Malawi-Liverpool-Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.; Jambo KC; Malawi-Liverpool-Wellcome Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.; Hoft DF; Division of Infectious Diseases, Allergy & Immunology, Center for Vaccine Development, and Department of Molecular Microbiology & Immunology, Saint Louis University School of Medicine, St. Louis, MO, USA.; Rubin EJ; Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.; Jamrozik E; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia; Ethox and Pandemic Sciences Institute, University of Oxford, Oxford, UK.; Fortune SM; Department of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health, Boston, MA, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE

Xu J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Halloran ME; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Moore M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Luedtke A; Department of Statistics, University of Washington, Seattle, WA, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Goepfert PA; The University of Alabama at Birmingham, Birmingham, AL, USA.; Gray G; South African Medical Research Council, Cape Town, South Africa.; Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil.; Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Falsey AR; Division of Infectious Diseases, Department of Medicine, University of Rochester, Rochester, NY, USA.; Robinson ST; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Garcia NMG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Zhou H; Biostatistics, Moderna, Cambridge, MA, USA.; van Dromme I; Johnson & Johnson, Beerse, Belgium.; Truyers C; Johnson & Johnson, Beerse, Belgium.; Hirsch I; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Neuzil KM; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. yunda@fredhutch.org.

Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE

Jatt LP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington.; Gillespie KM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Van P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Hoffman SL; Sanaria Inc., Rockville, Maryland.; Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, Washington.; Murphy SC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Department of Microbiology, University of Washington, Seattle, Washington.; Center for Emerging and Re-Emerging Infectious Diseases, University of Washington, Seattle, Washington.; Heath JR; Institute for Systems Biology, Seattle, Washington.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Global Health, University of Washington, Seattle, Washington.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Ashby E; Department of Biostatistics, University of Washington, Seattle, WA 98195, United States.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.; Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-9820, United States.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.; Zhou H; Infectious Disease Development, Moderna, Inc., Cambridge, MA 02142, United States.; Wang X; Infectious Disease Development, Moderna, Inc., Cambridge, MA 02142, United States.; Girard B; Infectious Disease Development, Moderna, Inc., Cambridge, MA 02142, United States.; Priddy F; Infectious Disease Development, Moderna, Inc., Cambridge, MA 02142, United States.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98115, United States.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201-1509, United States.; Baden LR; Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.; El Sahly HM; Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX 77030, United States.; Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7910653 Publication Model: Print Cited Medium: Internet ISSN: 1476-6256 (Electronic) Linking ISSN: 00029262 NLM ISO Abbreviation: Am J Epidemiol Subsets: MEDLINE

Gustin AT; Department of Immunology, University of Washington, Seattle, WA, USA.; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Broedlow CA; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Department of Pharmaceutics, University of Washington, Seattle, WA, USA.; Division of Surgical Outcomes and Precision Medicine Research, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Hager K; Seattle Malaria Clinical Trials Center, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Coronado E; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Department of Pharmaceutics, University of Washington, Seattle, WA, USA.; Wangari S; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Iwayama N; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Ahrens CY; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Garrison WD; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Guerriero KA; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Veterinary Medicine and Resources Branch, National Institute of Mental Health, Bethesda, MD, USA.; De Paris K; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Londono-Renteria B; Department of Tropical Medicine and Infectious Disease, Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, LA, USA.; Gale M Jr; Department of Immunology, University of Washington, Seattle, WA, USA.; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Department of Microbiology and Immunology, and Institute on Infectious Diseases, University of Minnesota School of Medicine, Minneapolis, MN, USA.; Klatt NR; Washington National Primate Research Center, University of Washington, Seattle, WA, USA.; Department of Pharmaceutics, University of Washington, Seattle, WA, USA.; Division of Surgical Outcomes and Precision Medicine Research, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Kublin JG; Seattle Malaria Clinical Trials Center, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Manuzak JA; Washington National Primate Research Center, University of Washington, Seattle, WA, USA. jmanuzak@tulane.edu.; Department of Pharmaceutics, University of Washington, Seattle, WA, USA. jmanuzak@tulane.edu.; Division of Immunology, Tulane National Biomedical Research Center, Tulane University, Covington, LA, USA. jmanuzak@tulane.edu.; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA. jmanuzak@tulane.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Parameswaran L; New York University Langone Vaccine Center, New York University Grossman School of Medicine, New York, New York, USA.; Goepfert PA; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Falsey AR; Infectious Disease Division, University of Rochester, Rochester, New York, USA.; Ludwig J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Rouphael N; Hope Clinic, Emory University, Atlanta, Georgia, USA.; Sobieszczyk ME; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Gray GE; South African Medical Research Council, Cape Town, South Africa.; Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Gay CL; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.; Greninger AL; Department of Medicine, Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.; Tapia MD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Hammershaimb EA; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Priddy FH; Moderna, Inc, Cambridge, Massachusetts, USA.; Green JA; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom.; Struyf F; Janssen Research and Development, Beerse, Belgium.; Dunkle L; Novavax, Inc, Gaithersburg, Maryland, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Biostatistics, University of Washington; Seattle, WA, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Global Health, University of Washington; Seattle, WA 98195, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Biostatistics, University of Washington; Seattle, WA, USA.; Woo W; Novavax, Inc.; Gaithersburg, MD, USA.; McGarry A; Novavax, Inc.; Gaithersburg, MD, USA.; Áñez G; Novavax, Inc.; Gaithersburg, MD, USA.; Dunkle LM; Novavax, Inc.; Gaithersburg, MD, USA.; Cho I; Novavax, Inc.; Gaithersburg, MD, USA.; Houchens CR; Biomedical Advanced Research and Development Authority; Washington, DC, USA.; Martins K; Biomedical Advanced Research and Development Authority; Washington, DC, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority; Washington, DC, USA.; Castellino F; Biomedical Advanced Research and Development Authority; Washington, DC, USA.; Petropoulos CJ; LabCorp-Monogram Biosciences; South San Francisco, CA, USA.; Leith A; Nexelis; Seattle, WA, USA.; Haugaard D; Nexelis; Seattle, WA, USA.; Webb W; Nexelis; Seattle, WA, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Randhawa AK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Hutter J; Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH; Rockville, MD, USA.; Keshtkar-Jahromi M; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH; Rockville, MD, USA.; Beresnev TH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH; Rockville, MD, USA.; Rodriguez CA; Division of Pediatric Infectious Diseases, University of South Florida, Morsani College of Medicine; Tampa, FL, USA.; Tapia M; Center for Vaccine Development and Global Health, University of Maryland School of Medicine; Baltimore, MD, USA.; Turley CB; Atrium Health Wake Forest School of Medicine; Charlotte, NC, USA.; Zorrilla CD; Obstetrics and Gynecology Department, School of Medicine, University of Puerto Rico, Medical Sciences Campus; San Juan, Puerto Rico.; Cohen SH; University of California Davis Medical Center, Department of Internal Medicine, Division of Infectious Diseases; Sacramento, CA, USA.; Kline SE; University of Minnesota Medical School, Department of Medicine, Division of Infectious Diseases and International Medicine; Minneapolis, Minnesota, USA.; Barranco E; Ponce Health Sciences University; Ponce, Puerto Rico.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington; Seattle, WA, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine; Baltimore, MD, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA.; Ake JA; U.S. Military HIV Research Program, Center for Infectious Disease Research, Walter Reed Army Institute of Research; Silver Spring, MD, USA.; Gay CL; University of North Carolina School of Medicine; Chapel Hill, NC, USA.; Kotloff KL; Center for Vaccine Development and Global Health, University of Maryland School of Medicine; Baltimore, MD, USA.; Jones T; Biomedical Advanced Research and Development Authority; Washington, DC, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD, USA.; Donis RO; Biomedical Advanced Research and Development Authority; Washington, DC, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center; Seattle, WA, USA.; Department of Biostatistics, University of Washington; Seattle, WA, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Samandari T; COVID-19 Prevention Network, Seattle, Washington, USA.; Achola M; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.; Hutter JN; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.; Mboya G; Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.; Otieno W; U.S. Army Medical Research Directorate-Africa, Kisumu, Kenya.; Kee JJ; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Huang Y; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washtington, USA.; Aponte JJ; PATH Center for Vaccine Innovation and Access, Geneva, Switzerland.; Ockenhouse CF; PATH Center for Vaccine Innovation and Access, Washington, District of Columbia, USA.; Lee CK; PATH Center for Vaccine Innovation and Access, Washington, District of Columbia, USA.; Polakowski L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.; Yacovone M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA.; Tapley A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Cape Town, Cape Town, South Africa.; Dadabhai S; Johns Hopkins Bloomberg School of Public Health, Blantyre, Malawi.; Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Kaldine H; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Bhebhe S; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Moore PL; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa.; SA MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Hural J; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Garrett N; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Kublin JG; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Luedtke A; Department of Statistics, University of Washington, Seattle, WA 98195, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; van der Laan L; Department of Statistics, University of Washington, Seattle, WA 98195, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Heng F; Department of Mathematics and Statistics, University of North Florida, Jacksonville, FL 32224, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Roels S; Johnson & Johnson Innovative Medicine, Janssen Pharmaceutica NV, 2340 Beerse, Belgium.; Le Gars M; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Van Roey GA; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Stieh DJ; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Van Dromme I; Johnson & Johnson Innovative Medicine, Janssen Pharmaceutica NV, 2340 Beerse, Belgium.; Kenny A; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27710, USA.; Global Health Institute, Duke University, Durham, NC 27710, USA.; Carone M; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ayala V; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC 20201, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC 20201, USA.; Castellino F; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC 20201, USA.; Amoa-Awua O; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Basappa M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Moore C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Naisan M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Naqvi M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; O'Connell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Mueller A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Serebryannyy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Castro M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Wang J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Dziubla G; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Randhawa AK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Hendriks J; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Truyers C; Johnson & Johnson Innovative Medicine, Janssen Pharmaceutica NV, 2340 Beerse, Belgium.; Struyf F; Johnson & Johnson Innovative Medicine, Janssen Pharmaceutica NV, 2340 Beerse, Belgium.; Schuitemaker H; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Douoguih M; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town 7925, South Africa.; Desmond Tutu HIV Centre, University of Cape Town, Cape Town 7705, South Africa.; Garrett N; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban 4041, South Africa.; Cardoso SW; Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro CEP 21.040-900, Brazil.; DelaFontaine P; Department of Medicine, Tulane University, New Orleans, LA 70112, USA.; Department of Physiology, Tulane University, New Orleans, LA 70112, USA.; Department of Pharmacology, Tulane University, New Orleans, LA 70112, USA.; Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Vingerhoets J; Johnson & Johnson Innovative Medicine, Janssen Pharmaceutica NV, 2340 Beerse, Belgium.; Casapia M; Facultad de Medicina Humana, Universidad Nacional de la Amazonia Peru, Iquitos 16004, Peru.; Losso MH; Hospital General de Agudos José María Ramos Mejia, Buenos Aires 1221, Argentina.; Little SJ; Division of Infectious Diseases, University of California, San Diego, La Jolla, CA 92037, USA.; Gaur A; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.; Swann E; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Petropoulos CJ; LabCorp-Monogram Biosciences, South San Francisco, CA 94080, USA.; McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Sadoff J; Johnson & Johnson Innovative Medicine, Janssen Vaccines & Prevention B.V., 2301 Leiden, the Netherlands.; Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.; South African Medical Research Council, Cape Town 7505, South Africa.; Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro CEP 21.040-900, Brazil.; Goepfert PA; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Roychoudhury P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Greninger AL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; Donis RO; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC 20201, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Kenny A; Department of Biostatistics, University of Washington, Seattle, WA, USA.; van Duijn J; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Dintwe O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Heptinstall J; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Burnham R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Sawant S; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Zhang L; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Mielke D; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Khuzwayo S; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Omar FL; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Stanfield-Oakley S; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Keyes T; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Dunn B; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA.; Goodman D; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Zou R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Luedtke A; Department of Statistics, University of Washington, Seattle, WA, USA.; van der Laan L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Statistics, University of Washington, Seattle, WA, USA.; Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Magaret C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Pattacini L; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; van de Kerkhof T; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Korber B; Los Alamos National Laboratory, Los Alamos, NM, USA; New Mexico Consortium, Los Alamos, NM, USA.; Willems W; Janssen Research & Development BE, Beerse, Belgium.; Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Schuitemaker H; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Swann E; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Pau MG; Janssen Infectious Diseases BV, Beerse, Belgium.; Buchbinder S; San Francisco Department of Public Health, San Francisco, CA, USA.; Tomaka F; Janssen Research & Development, LLC, Titusville, NJ, USA.; Nijs S; Janssen Infectious Diseases BV, Beerse, Belgium.; Lavreys L; Janssen Infectious Diseases BV, Beerse, Belgium.; Gelderblom HC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, 98195, USA.; Mngadi K; The Aurum Institute, Johannesburg, South Africa.; Gray GE; South African Medical Research Council, Cape Town, South Africa.; Borducchi E; Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Hendriks J; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Seaton KE; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; Zolla-Pazner S; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Barouch DH; Center for Virology & Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.; Ferrari G; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA.; De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Andersen-Nissen E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa.; Stieh DJ; Janssen Vaccines & Prevention BV, Leiden, the Netherlands.; Tomaras GD; Center for Human Systems Immunology, Department of Surgery, Duke University, Durham, NC, USA; Duke Human Vaccine Institute, Durham, NC, USA; Department of Integrative Immunobiology, Duke University, Durham, NC, USA. Electronic address: georgia.tomaras@duke.edu.; Gilbert PB; Department of Biostatistics, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address: pgilbert@fredhutch.org.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE; In Process

Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Roels S; Johnson & Johnson Innovative Medicine, Beerse, Belgium.; Stieh DJ; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Vaccine Company Inc., South San Francisco, CA, USA.; Van Dromme I; Johnson & Johnson Innovative Medicine, Beerse, Belgium.; Van Roey GA; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Kenny A; Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.; Duke Global Health Institute, Duke University, Durham, NC, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.; Carone M; Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA.; McDermott AB; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Sanofi Vaccines R&D, Marcy l'étoile, France.; Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Castellino F; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Amoa-Awua O; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Basappa M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Flach B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Lin BC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Moore C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Naisan M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Naqvi M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Narpala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; O'Connell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Mueller A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Serebryannyy L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Castro M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Wang J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Petropoulos CJ; LabCorp-Monogram Biosciences, South San Francisco, CA, USA.; Luedtke A; Department of Statistics, University of Washington, Seattle, WA, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hejazi NS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.; Wolfe DN; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Sadoff J; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Centivax, South San Francisco, CA, USA.; Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council, Cape Town, South Africa.; Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.; Goepfert PA; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.; Department of Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa.; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; Gaur AH; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.; Veloso VG; Evandro Chagas National Institute of Infectious Diseases-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.; Randhawa AK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Hendriks J; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Truyers C; Johnson & Johnson Innovative Medicine, Beerse, Belgium.; Vandebosch A; Johnson & Johnson Innovative Medicine, Beerse, Belgium.; argenx BV, Ghent, Belgium.; Struyf F; Johnson & Johnson Innovative Medicine, Beerse, Belgium.; GSK, Wavre, Belgium.; Schuitemaker H; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Valneva, Saint-Herblain, France.; Douoguih M; Janssen Vaccines and Prevention, Leiden, the Netherlands.; Merck, Rahway, NJ, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Fogarty International Center, Bethesda, MD, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. pgilbert@fredhutch.org.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. pgilbert@fredhutch.org.; Department of Biostatistics, University of Washington School of Public Health, Seattle, WA, USA. pgilbert@fredhutch.org.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Chu E; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kenny A; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Carone M; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; van der Laan LWP; Department of Statistics, University of Washington, Seattle, WA, USA.; Deng W; Moderna, Inc, Cambridge, MA, USA.; Zhou H; Moderna, Inc, Cambridge, MA, USA.; Wang X; Moderna, Inc, Cambridge, MA, USA.; Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Chen H; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Reeder I; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Fichtenbaum CJ; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA.; Kalams S; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.; Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.; Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.; Priddy F; Moderna, Inc, Cambridge, MA, USA.; Das R; Moderna, Inc, Cambridge, MA, USA.; Girard B; Moderna, Inc, Cambridge, MA, USA.; El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.; Baden LR; Brigham and Women's Hospital, Boston, MA, USA.; Jones T; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA.; Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. dfollmann@niaid.nih.gov.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Balasingam S; Infectious Disease, Wellcome Trust, London, United Kingdom.; Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and University of Cape Town (UCT) Lung Institute and South African Medical Research Council/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, South Africa.; Fortune S; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Gordon SB; Clinical Experimental Medicine, Malawi Liverpool Wellcome Programme, Blantyre.; Hoft D; Departments of Internal Medicine and Molecular Microbiology & Immunology, Saint Louis University of Medicine, Missouri.; Kublin JG; Cancer Center, Vaccine and Infectious Disease Division, Fred Hutchinson Institute, Seattle, Washington.; Loynachan CN; Infectious Disease, Wellcome Trust, London, United Kingdom.; McShane H; The Jenner Institute, University of Oxford, United Kingdom.; Morton B; Department of Clinical Sciences, Liverpool School of Tropical Medicine, United Kingdom.; Nambiar S; TB Impact Area, International AIDS Vaccine Initiative, New York, New York.; Sharma NR; Infectious Disease, Wellcome Trust, London, United Kingdom.; Robertson B; Department of Infectious Disease, Imperial College London, United Kingdom.; Schrager LK; TB Impact Area, International AIDS Vaccine Initiative, New York, New York.; Weller CL; Infectious Disease, Wellcome Trust, London, United Kingdom.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

Sherman AC; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Tuan J; Yale School of Medicine, Section of Infectious Diseases, New Haven, Connecticut, USA.; Cantos VD; Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA.; Adeyiga O; Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California, USA.; Mahoney S; Department of Medicine, University of Cape Town, Desmond Tutu HIV Centre, Cape Town, South Africa.; Ortega-Villa AM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Tillman A; Frederick National Laboratory for Cancer Research, Clinical Monitoring Research Program Directorate, Frederick, Maryland, USA.; Whitaker J; Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Woodward Davis AS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Leav B; Moderna Inc., Cambridge, Massachusetts, USA.; Hirsch I; Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Sadoff J; Janssen Vaccines and Prevention, Leiden, Netherlands.; Dunkle LM; Novavax, Gaithersburg, Maryland, USA.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Kotloff K; Department of Pediatrics and the Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Rouphael N; Hope Clinic, Emory University, Atlanta, Georgia, USA.; Falsey AR; Infectious Disease Division, University of Rochester, Rochester, New York, USA.; El Sahly HM; Department of Molecular Virology and Microbiology and Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.; Sobieszczyk ME; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.; Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Grinsztejn B; National Institute of Infectious Diseases-Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Gray G; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council, Cape Town, South Africa.; Nason M; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Baden LR; Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE